Bing Xin

Clofibric acid, a peroxisome proliferator–activated receptor α ligand, inhibits growth of human ovarian cancer

Yoshihito Yokoyama, Bing Xin, Tatsuhiko Shigeto et al. · Molecular Cancer Therapeutics · 2007 · 87 citations · Full text

Inhibitory effect of meloxicam, a selective cyclooxygenase‐2 inhibitor, and ciglitazone, a peroxisome proliferator‐activated receptor gamma ligand, on the growth of human ovarian cancers

Bing Xin, Yoshihito Yokoyama, Tatsuhiko Shigeto et al. · Cancer · 2007 · 59 citations

Peroxisome proliferator-activated receptor α and γ ligands inhibit the growth of human ovarian cancer

Tatsuhiko Shigeto, Yoshihito Yokoyama, Bing Xin et al. · Oncology Reports · 2007 · 58 citations · Full text

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

Yoshihito Yokoyama, Bing Xin, Tatsuhiko Shigeto et al. · Journal of Cancer Research and Clinical Oncology · 2011 · 45 citations · Full text

Oncology, Medicine, Gynecology +7

Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers

Bing Xin, Yoshihito Yokoyama, Tatsuhiko Shigeto et al. · Pathology & Oncology Research · 2007 · 38 citations

Anti-tumor Effect, Medicine, Pharmacology +8